Field immobilization of captive antelope may be required for medical examination, blood sample collection, and animal identification. The aim of this study was to evaluate the effects of a combination of butorphanol, detomidine, and midazolam (BDM) and its partial reversibility in Nile lechwe antelope (Kobus megaceros). Nine captive lechwes, weighing 28-64 kg, were immobilized, in February 2011, with butorphanol 0.2060.05 (mean6SD) mg/kg, detomidine 0.2060.05 mg/kg, and midazolam 0.3160.08 mg/kg administered intramuscularly (IM) with a blowpipe. Physiologic parameters and depth of anesthesia were recorded when the animals became recumbent at 19.5568.36 min after darting (T0) and after 10 (T10), 20 (T20), and 30 (T30) min. An arterial blood sample was collected at T20. At the end of the procedures, immobilization was partially reversed with atipamezole 0.25 mg/kg IM. Quality of induction, immobilization, and recovery was scored. The BDM combination induced immobilization and lateral recumbency in 13.4465.61 min. Median induction score (scored 1 [excellent] to 4 [poor]) was 1 (range 1-2). Heart rate varied 40-104 beats/min, respiratory rate 16-108 breaths/min, and rectal temperature 36.5-40.3 C. Hyperthermia was observed and rapidly treated in three animals that demonstrated insufficient immobilization after darting. Arterial blood gas analyses revealed a mean pH of 7.4360.07, partial arterial pressure of CO 2 of 44.166.0 mmHg, partial arterial pressureof O 2 of 74.0613.5 mmHg, and an arterial O 2 saturation of 94.7763.96%. Recovery was smooth and animals were walking in 13.4467.85 min. Median recovery score (1 5 excellent to 4 5 poor) was 1 (range 1-2). The BDM was effective in immobilizing captive healthy lechwes with minimal cardiorespiratory changes.
INTRODUCTION
The Nile lechwe (Kobus megaceros) is an endangered species of antelope found in floodplains in southern Sudan and far western Ethiopia. Adult male lechwes stand 90-100 cm at top of the dorsal thoracic spines and weigh 70-110 kg; they live in marshy areas and eat mainly aquatic plants (ISIS Group, 2008) . According to the International Species Information System (ISIS, 2011) , captive Nile lechwes are held in collections in North America, Europe, the Middle East, and Asia.
Immobilization of captive antelope may be required to perform basic demographic and identification procedures for medical and research purposes. The main requirements for safe anesthesia in antelope are a rapid and adequate immobilization, minimal cardiovascular and respiratory impairment, and rapid and smooth recovery (Ball, 2007) . Opioids (thiafentanil, carfentanil, etorphine, butorphanol) have been the most commonly used class of drugs for immobilization in antelope together with a 2 agonists (xylazine, detomidine, medetomidine) and dissociative anesthetics (tiletamine, ketamine; Citino et al., 2001 Citino et al., , 2002 Cooper et al., 2005; Ball, 2007) . The benefits of these drug combinations include lowering the dose of each drug using reduced volumes, shortening induction time, and assuring muscle relaxation. Potential disadvantages of these combinations are prolonged and stormy (with dysphoria, ataxia, agitation) recovery (dissociative anesthetics), respiratory depression (opioids), hypersalivation, and muscle rigidity (dissociative anesthetics; Ball, 2007) . Antelope, like all small ruminants, are susceptible to stress, ruminal tympany, regurgitation, and aspiration leading to pneumonia during general anesthesia (Ball, 2007) and it is critical to avoid drugs or techniques that promote such complications.
Butorphanol is a narcotic agonist/antagonist, analgesic, and mild tranquilizer that has been used in combination with tiletamine-zolazepam and an a 2 -agonist in other species of antelope (Addax nasomaculatus, Taurotragus oryx, Oryx dammah, Aepyceros melampus, Connochaetes taurinus, and Antilope cervicapra; Paras et al., 2002) . Detomidine is a potent a 2 -agonist, sedative, and analgesic that has been used in Addax nasomaculatus in combination with opioids (Portas et al., 2003) . Midazolam is a benzodiazepine tranquillizer and muscle relaxant whose use has not been reported in antelope. However, midazolam is an effective sedative in domestic sheep (Ovis aries) and goats (Capra aegagrus), producing sedation and recumbency when used alone at dosages .0.2 mg/kg (Kyles et al., 1995; Galatos, 2011) .
We speculate that the addition of midazolam to detomidine and butorphanol could avoid the use of dissociative anesthetics, providing an adequate level of immobilization in captive Nile lechwe antelope. Our aim was to evaluate the sedative, cardiovascular, and respiratory effects of a butorphanol, detomidine, and midazolam (BDM) combination and its partial reversal with atipamezole for the immobilization of a colony of nine lechwes.
MATERIALS AND METHODS
Two male and seven female adult captive lechwes with a mean age of 6.7762.86 yr (range 2-10 yr) were immobilized for routine clinical procedures and identification at the Zoo of Naples, Italy (40u49923.200N, 14u10953 .570E) in January 2011. Three days before the procedure the antelope were brought into a 1-ha restricted area. Food but not water was withheld for 24 hr. All animals were anesthetized with BDM. The body weight (BW) of each lechwe was estimated (by P.L.) before darting.
Immobilization was achieved by intramuscular (IM) remote injection in the upper hind leg area using a blowpipe of 100 or 140 cm (TeleDart Blowpipe B11 or Blowpipe B14, TeleDartH, Boulder, Colorado, USA), a 3-or 5-ml dart syringe (BD3 or BD5, TeleDart), and a plain 30-mm needle with an internal diameter of 1.1 mm (BN1130, TeleDart). The operator was positioned outside the fence, behind a shade net at a maximum distance of 3 m. Animals of BW estimated .30 kg received a combination of 10 mg (1 ml) of butorphanol (Dolorex 1%, Intervet, Milan, Italy), 10 mg (1 ml) of detomidine (Medesedan 1%, Virbac, Milan, Italy), and 15 mg (3 ml) of midazolam (Midazolam 0.5%, I.B.I, Aprilia, Italy). Animals of estimated BW ,30 kg were injected with half of the dose reported above (half dose). The dosages of drugs were based on the personal experience of P.L., who used BDM in preliminary trials (four cases) in the same zoo and with the same population of animals.
Time (min) from darting to the first signs of sedation (darting-sedation; ataxia, weakness, head dropping) and to recumbency (dartingrecumbency) was recorded for each animal. The quality of induction was assessed by a descriptive score ranging from 1 (excellent) to 4 (poor; Table 1 ). When induction was insufficient the animal received a second half (score 3) or full (score 4) dose of BDM. After immobilization was sufficient (no reaction to auditory stimuli such as shouting and handclapping) the animal was approached from behind and blindfolded. Time from injection to first approach was recorded (dartingapproach). Once the animal was approached the quality of immobilization (immobilization score) was assessed by checking palpebral, pedal, and anal reflexes, jaw tone, presence of voluntary tail movements, and reaction to painful stimuli (ear notching), and it was scored from 1 (very light sedation) to 6 (excessive sedation; Table 2 ). If the immobilization score was 1 or 2 a second half-dose of BDM was administered. Heart rate (HR, beats/min) by thoracic auscultation, respiratory rate (RR, breaths/min) by observation of chest wall movement, and rectal temperature (T) were monitored every 5 min during the procedure and recorded at the time of the first approach (T0) and at 10 (T10), 20 (T20), and 30 (T30) min. Lechwes were weighed on a portable dynamometric electronic scale (CASH NC1 1000 crane scale, Rutherford, New Jersey, USA). Venous (jugular vein) and arterial (femoral artery) blood samples were collected at T20. The arterial samples (3 ml collected in heparinized syringes) were immediately analyzed using a portable blood gas analyzer (IDEXX VetStat, IDEXX Laboratories, Inc. Westbrook, Minnesota, USA). The measured and calculated parameters were pH, partial arterial pressure of carbon dioxide (P a CO 2 , mmHg), partial arterial pressure of oxygen (P a O 2 , mmHg), base excess (BE, mmol/l), bicarbonate concentration (HCO 3 2 , mmol/l), anion gap (AnGap, mmol/l), hemoglobin concentration (tHb, g/dl), and oxygen hemoglobin saturation (S a O 2 , %), the Na
and Cl 2 concentration (mmol/l), and the arterial content of oxygen (C a O 2 , vol%). All parameters were corrected for the rectal temperature measured at the time of sampling. The alveolar to arterial oxygen pressure gradient P (A-a) O 2 was calculated as:
where P B is the barometric pressure, P H2O the water vapor pressure, FiO 2 the inspired oxygen fraction, and R the respiratory exchange ratio, assumed to be 0.9. The P B was recorded by the ABG analyzer during each analysis, and the P H2O was corrected for the rectal temperature recorded at the time of arterial blood collection. The venous blood samples were stored in ice and analyzed within 12 hr for the measurement of the main hematologic parameters. During immobilization, animals were kept in sternal recumbency with the neck held up and the mouth facing down to prevent regurgitation and aspiration Induction score Description 1 Slight ataxia followed by one or two attempts to sit or lie in sternal recumbency without signs of excitement due to central nervous system (CNS) stimulation or falling; followed by smooth transition to lateral recumbency (excellent). 2
Moderate ataxia followed by one or two attempts to sit and or lie in sternal recumbency. There may be some initial symptoms of CNS stimulation or the animal may stumble (good). 3
Severe ataxia followed by numerous attempts to sit or lie down. Symptoms of marked CNS stimulation or animal stumbles and falls on multiple occasions before becoming recumbent. Risk of injury to the animal (fair). 4
Severe ataxia but animal does not become recumbent. Marked CNS stimulation or animal stumbles and falls repeatedly. Animal requires second dose of drugs before becoming recumbent (poor). of ruminal content. During the immobilization all lechwes were microchipped. At the end of the procedure, sedation was partially reversed with atipamezole (Antisedan 0.5%, Pfizer, Milan, Italy) at the dose of 0.25 mg/kg IM on the basis of the measured BW. Times between atipamezole administration and the first head movements (atipamezole-first movements) and standing (atipamezole-standing) were recorded. Quality of recovery was assessed using a scoring system ranging from 1 (excellent) to 4 (poor) ( Table 3) . Any side effects noted during the procedure and for the following 24 hr were recorded. For all data the mean, standard deviation, and range (parametric data: physiologic, blood gas, and hematologic parameters) or median and range (nonparametric data: induction, immobilization, and recovery scores) were calculated. Parametric physiologic parameters were compared among study times (T0, T10, T20, and T30) using one-way analysis of variance for repeated measures (P,0.05) using MedCalc.v9.2.0.1 (MedCalc Software, Mariakerke, Belgium).
RESULTS
The study was completed in all animals without major complications. Seven (of nine) patients were injected in the caudal part of the upper hind leg at the level of the semimembranosus, semitedinosus muscles and two were injected at the level of the tensor fasciae latae muscle. The mean measured BW was 50.88614.46 kg (range 28-70 kg) and all animals were considered healthy on the basis of physical examination during immobilization. Drug dosages on the basis of measured BW were: detomidine, 0.20860.056 mg/kg (range 0.142-0.294 mg/kg); butorphanol, 0.20860.056 mg/kg (range 0.142-0.294 mg/kg); and midazolam, 0.31260.085 mg/kg (range 0.214-0.441 mg/kg). These doses include the additional drugs administered to some animals to obtain complete immobilization. The first signs of sedation (darting-sedation) were observed in 6.1163.72 min (range 1-12 min) after darting (Table 4) . Recumbency was achieved in 13.4465.61 min (range 5-21 min) after darting. Median induction score was 1.00 (range 1-2). Animals were approached (darting-approach) in 19.556 8.36 min (range 5-31 min) after darting. The median immobilization scores at the different times are reported in Table 4 . Three lechwes (33.4%) required the administration of a second dose (half dose) of BDM at T0. During the immobilization, Animal makes frequent attempts with severe ataxic movements to transition from lateral to sternal recumbency before being successful. Severe imbalance in sternal recumbency. Makes numerous attempts to stand but frequently falls before being successful and displays marked ataxia when walking. Recovery to walking .30 min following administration of drug antagonists (fair). 4
Animal remains in lateral recumbency .30 min following the administration of drug antagonists, is not responsive to stimuli, and makes no attempt to transition to sternal recumbency. Or, animal has an agitated recovery with marked ataxia with the potential for injury. May require sedation (poor).
HR varied from 40 to 104 beats/min, RR from 16 to 108 breaths/min, and rectal temperature from 36.6 to 40.3 C with no statistical difference between study times (Table 4) . Hyperthermia (39.5-40.3 C) was observed in the same three animals that required an additional dose for immobilization. It was rapidly treated with topical application of ice and alcohol on the body surface and no further complications were noted. Mean values of the blood gas and hematologic parameters are reported in Tables 5 and 6 . Atipamezole was administered 57.22612.78 min (range 41-77 min) after darting (darting-atipamezole). After reversal administration, head movements were observed at 9.8866.19 min (range 1-20 min), and lechwes were standing/walking at 13.4467.85 min (range 4-30 min). The median recovery score was 1 (range 1-2), with only one animal that demonstrated a mild ataxic and uncoordinated recovery. No side effects or complications were noted in any animal during the first 24 hr after the procedure.
DISCUSSION
The combination of butorphanol, detomidine, and midazolam and its partial antagonism with atipamezole was an adequate and safe protocol for immobilization of captive lechwes for short, noninvasive procedures (30-45 min). Antelope are prey animals that tend to be stressed and attempt to escape when a threat is perceived (Ball, 2007) . Consequently hyperthermia and capture myopathy are possible complications during immobilization (Ball, 2007; Jacques et al., 2009) . To avoid these complications, drugs should produce rapid sedation and immobilization. The BDM protocol demonstrated a reasonable induction time, with the first signs of sedation appearing in 6 min and recumbency in an average of 13 min. The median induction score was excellent/good, with the animals making one or two attempts to lie in sternal or lateral recumbency without or with very mild signs of excitement (scores 1 and 2, Table 1 ). The level of immobilization was (Ball, 2007) . The anesthetic drugs and positioning of the animals play an important role in the incidence of regurgitation. In particular it is reported that in small ruminants a light level of sedation stimulates active regurgitation, and left lateral recumbency may promote tympany and passive regurgitation (Riebold, 2007) . Tympany also may have a negative influence on lung function during immobilization, reducing the diaphragmatic excursion and compressing the pulmonary parenchyma (Musewe et al., 1979; Desmecht et al., 1995) .
Because there were no clinical signs of tympany in our animals, we speculate that the mild respiratory depression (slight hypercapnia) in some patients could be related to the depressive effect of the drugs on the central and peripheral CO 2 responses. However, oxygenation was always acceptable in all patients (S a O 2 .90%) considering that they were breathing ambient air, and only one animal had a P a O 2 slightly lower than 60 mmHg (54 mmHg).
Placing a stomach and a tracheal tube are considered procedures that may have an important impact in preventing regurgitation and aspiration in small ruminant anesthesia (Galatos, 2011) . However, these interventions are invasive and may require deeper anesthesia than necessary for short, otherwise noninvasive procedures. Our use of BDM was not associated with any of the aforementioned complications and thus may be suitable for short procedures. In our study the positioning of the animals during immobilization (sternal recumbency with the neck held up and the mouth facing down) was effective in preventing regurgitation. Nevertheless the equipment required to perform tracheal or gastric intubation always should be readily available during anesthesia in the case of longer and more invasive procedures and in case complications should arise.
The three lechwes that experienced hyperthermia were the same that required an additional dose of the drugs due to insufficient immobilization, confirming the critical role that the quality of immobilization may have in the development of hyperthermia in these animals (Caulkett and Arnemo, 2007) . Despite the absence of any major hypnotic drug, all the animals experienced an optimal level of sedation characterized by a complete muscle relaxation, without spontaneous movement, and with the tongue extractable. The combination of a potent a 2 -agonist (detomidine) and midazolam appeared to induce deep sedation without major cardiovascular side effects and the HR was stable during immobilization. Recovery from immobilization is a critical phase in lechwes. Agitation, ataxia, and injuries are possible complications during recovery (Ball, 2007) . The antagonism of detomidine was sufficient for complete recovery in our animals. The recovery score was excellent/good in all animals without signs of excitement or agitation. The dose of atipamezole was constant, independent of the amount of detomidine administered, and was based on the results of the preliminary trials. The constant dose of atipamezole can in part justify the wide range of head lifting times (1-20 min) considering that some patients received a higher amount of detomidine. In particular, the three antelope that required an additional dose of the drugs had longer times to first head movement (.15 min) than the rest of the group (,10 min). We speculate that a dose of atipamezole proportional to the dose of detomidine (one-to twofold) should reduce the variability in time to head movement. Atipamezole was effective in antagonizing the most potent sedative of the combination and the residual sedative effects of butorphanol and midazolam were effective in producing mild sedation, avoiding stress and agitation to the animals. However, we should also consider the possibility of a complete reversal (naltrexone or naloxone for opioids and flumazenil for midazolam) in free-ranging animals to avoid problems related to residual sedation.
In conclusion, the combination of butorphanol, detomidine, and midazolam, and its partial antagonism with atipamezol, was effective in producing a short-time immobilization in captive Nile lechwes, avoiding the use of dissociative anesthetics or potent opioids that have been traditionally used in antelope.
